Error: Could not add to watchlist. X
+ Watchlist

Optimer Pharmaceuticals LLC

OPTR:US
Acquired
OPTR:US was acquired by MRK:US
USD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-2.17
Market Cap (USD)
-
Shares Outstanding (m)
48.900
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Optimer Pharmaceuticals, Inc. discovers, develops, and commercializes anti-infective products. Optimer's initial development efforts address products that treat gastrointestinal infections (GI) and related diseases, including diminished efficacy, serious adverse side effects, drug-to-drug interactions, difficult patient compliance, and bacterial resistance.
Address
101 Hudson Street
Suite 3501
Jersey City, NJ 07302
United States
Phone
1-201-333-8819
Website
-
  • Eric Sirota
    Chief Operating Officer
  • Meredith Schaum
    Chief Compliance Ofcr/Gen Cnsl
  • Sherwood L Gorbach
    Senior VP/Chief Scientific Ofcr
  • Linda E Amper
    Senior VP:Human Resources
Show More